Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score‑matched analysis

Fig. 4

Subgroup forest plots of T2D patients with ACS prescribing SGLT2i vs SGLT2i-free. A Subgroup forest plot for major adverse cardiac events (MACE). B Subgroup forest plot for heart failure readmission. ACS, acute coronary syndrome; BMI, body mass index; eGFR, estimated glomerular filtration rate; SGLT2i, sodium-glucose cotransporter 2; T2D, type 2 diabetes

Back to article page